I think we should be clear that Pfizer did not put $145M into TT-034. That amount was to take TT-034 to commercialisation, which obviously did not occur. No figure on the actual money spent has been released but best guesses on HC have previously been in the $10-12M ballpark. Even so, this is still a reasonable investment which I am sure they would like to recoup if they had the opportunity.